Cadherins as predictive markers of nodal metastasis in breast cancer

Modern Pathology

Volumn 14, Issue 5, 2001, Pages 423-427

  Madhavan, Maya ^a   Srinivas, Priya ^a   Abraham, Elizabeth ^a   Ahmed, Iqbal ^a   Mathew, Aleyamma ^a   Vijayalekshmi, N R ^b   Balaram, Prabha ^a  

^a REGIONAL CANCER CENTRE   (India)

^b UNIVERSITY OF KERALA   (India)

Author keywords

E cadherin; Immunohistochemistry Nodal metastasis; P cadherin

Indexed keywords

CADHERIN; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER INVASION; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; BREAST NEOPLASMS; CADHERINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LOGISTIC MODELS; LYMPH NODES; LYMPHATIC METASTASIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035038940     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880329     Document Type: Article

References (15)

1. Behrens J, Frixen U, Schipper J. Cell adhesion in cancer invasion and metastasis. Semin Cancer Biol 1992;3:169-178.
2. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem 1990;59:237-52.
3. Oka HS, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993;53:1696-701.
4. De Marzo AM, Knudsen B, Chan-Tack K, Epstein JI. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens. Urology 1999;53:707-13.
5. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck; inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991; 51:6328-37.
6. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarard DF, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995;55:5195-99.
7. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of junctions and the prevention of invasiveness. Biochim Biophys Acta 1994;198:11-26.
8. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HFM, Oosterhof GON, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994;54:3929-33.
9. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998;392:190-3.
10. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, et al. E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:173-85.
11. Gagliardi G, Kandemir O, Liu D, Guida M, Benvestito S, Ruers TGM. Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel. Virchows Archiv 1995;426:149-54.
12. St. Croix B, Sheehan C, Rak JW, Florenes VA, Slingisland JM, Kerbel RS. E-cadherin dependent growth suppression is mediated by the cyclin dependent kinase inhibitor p27 KIPI. J Cell Biol 1998;142:557-71.
13. Pece S, Chiariello M, Murga C, Gutkind JS. Activation of the protein kinase Akt/PKB by the formation of E-cadherin mediated cell-cell junctions. Evidence for the association of phosphoinositide-3-kinase with the E-cadherin adhesion complex. J Biol Chem 1999;274:19347-51.
14. Ito K, Okamoto T, Araki N, Kawano Y, Nakao M, Fujiyama S, et al. Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of β-catenin from cell-cell contacts. Oncogene 1999;18:7080-90.
15. Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the E-cadherin 5′CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275:2727-32.